Cargando…
Induction of Premature Senescence by Hsp90 Inhibition in Small Cell Lung Cancer
BACKGROUND: The molecular chaperone Hsp90 is a promising new target in cancer therapy and selective Hsp90 inhibitors are currently in clinical trials. Previously these inhibitors have been reported to induce either cell cycle arrest or cell death in cancer cells. Whether the cell cycle arrest is rev...
Autores principales: | Restall, Ian J., Lorimer, Ian A. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2884022/ https://www.ncbi.nlm.nih.gov/pubmed/20552022 http://dx.doi.org/10.1371/journal.pone.0011076 |
Ejemplares similares
-
Modelling the Role of the Hsp70/Hsp90 System in the Maintenance of Protein Homeostasis
por: Proctor, Carole J., et al.
Publicado: (2011) -
Induction of senescence in primary glioblastoma cells by serum and TGFβ
por: Kumar, Ritesh, et al.
Publicado: (2017) -
HSP-90 Inhibitor Ganetespib is Synergistic with Doxorubicin in Small Cell Lung Cancer
por: Lai, Chien-Hao, et al.
Publicado: (2013) -
HSP90 as a novel molecular target in non-small-cell lung cancer
por: Esfahani, Khashayar, et al.
Publicado: (2016) -
Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage
por: Park, Sangkyu, et al.
Publicado: (2019)